The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey (Sprit)
This study is currently recruiting participants.
Verified March 2012 by Chinese Medical Doctor Association
Sponsor:
Chinese Medical Doctor Association
Information provided by (Responsible Party):
Lin Shen，MD & Ruihua Xu，MD、PhD, Chinese Medical Doctor Association
ClinicalTrials.gov Identifier:
NCT01549067
First received: March 6, 2012
Last updated: March 13, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Collect the real clinical background of advanced colorectal cancer c of China.
| Condition |
|---|
|
Advanced Malignant Neoplasm Colorectal Cancer |
| Study Type: | Observational |
| Study Design: | Time Perspective: Cross-Sectional |
| Official Title: | The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey |
Resource links provided by NLM:
Further study details as provided by Chinese Medical Doctor Association:
| Estimated Enrollment: | 3700 |
| Study Start Date: | September 2011 |
| Estimated Study Completion Date: | December 2012 |
| Estimated Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
The Primary Objectives of this study is collect the real clinical background of advanced colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment situation of colorectal cancer patients.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Advanced Colorectal Cancer
Criteria
Inclusion Criteria:
- Patients with histologically or cytologically confirmed diagnosis of metastatic colorectal cancer.
Exclusion Criteria:
- Patients with histologically or cytologically confirmed diagnosis other than metastatic colorectal cancer.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01549067
Contacts
| Contact: Lin Shen, MD | 010-88140650 | lin100@medmail.com.cn |
| Contact: Rui-hua Xu, MD , PhD | 020-87343468 | xurh@sysucc.org.cn |
Locations
| China, Beijing | |
| Peking University Cancer Hospital | Recruiting |
| Beijing, Beijing, China | |
| Contact: Lin Shen, MD 010-88140650 lin100@medmail.com.cn | |
| Principal Investigator: Lin Shen, MD | |
| China, Guangzhou | |
| Sun Yat-sen University Cancer Center | Recruiting |
| Zhongshan, Guangzhou, China | |
| Contact: Rui-hua Xu, MD , PhD 020-87343468 xurh@sysucc.org.cn | |
| Principal Investigator: Rui-hua Xu, MD , PhD | |
Sponsors and Collaborators
Chinese Medical Doctor Association
Investigators
| Principal Investigator: | Lin Shen, MD | Peking University Cancer Hospital |
| Principal Investigator: | Ruihua Xu, MD, PhD | Sun Yat-sen University |
More Information
No publications provided
| Responsible Party: | Lin Shen，MD & Ruihua Xu，MD、PhD, Principal Investigator, Chinese Medical Doctor Association |
| ClinicalTrials.gov Identifier: | NCT01549067 History of Changes |
| Other Study ID Numbers: | Sprit |
| Study First Received: | March 6, 2012 |
| Last Updated: | March 13, 2012 |
| Health Authority: | China: Ethics Committee |
Keywords provided by Chinese Medical Doctor Association:
|
Advanced Colorectal Cancer Targeted chemotherapy Surgery Radiotherapy |
Additional relevant MeSH terms:
|
Neoplasms Colorectal Neoplasms Intestinal Neoplasms Gastrointestinal Neoplasms Digestive System Neoplasms Neoplasms by Site |
Digestive System Diseases Gastrointestinal Diseases Colonic Diseases Intestinal Diseases Rectal Diseases |
ClinicalTrials.gov processed this record on May 19, 2013